Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Category: National Health Security

BARDA Ventures: A New Approach to Partnership

Author: Sandeep Patel, Ph.D, BARDA DRIVe Director, and Justin Yang, MBA, Catalyst Office Director
Published Date: 11/19/2020 1:08:00 PM
Category: Medical Countermeasures; Observances; National Health Security;

How can we make sure our country has the vaccines, therapeutic treatments, diagnostics and other technology that are needed to save lives in a public health emergency? Part of the answer is encouraging innovators and entrepreneurs to partner with the federal government, and doing so requires rethinking the typical government approach to research, development and acquisition. Over the last decade, the success of HHS, ASPR, and BARDA has been to partner with the most innovative, fearless, and best partners in industry. These partnerships have helped push preparedness efforts farthe  Read more…

NDMS Trauma and Critical Care Team Supported Medical Professionals with Intubated COVID-19 Patients

Author: HHS Office of the Assistant Secretary for Preparedness and Response
Published Date: 11/17/2020 2:03:00 PM
Category: Response & Recovery; Public Health Preparedness; National Health Security; National Disaster Medical System;

HHS Supported Response to the Novel Coronavirus in El Paso, Continues Support Nationwide


As part of the response to the COVID-19 pandemic, approximately 100 experts from across the country deployed recently as part of the National Disaster Medical System (NDMS) to provide temporary medical surge support to three hospitals in El Paso, Texas. Although this mission has ended, NDMS responders continue to provide important services in other communities across the country.

Beyon  Read more…

BARDA Ventures: Evolving Federal National Health Security Using Novel Venture Capital-Style Partnership

Author: Gary Disbrow, Ph.D, Deputy Assistant Secretary for Preparedness and Response, Acting BARDA Director, and Sandeep Patel, Ph.D, BARDA DRIVe Director, and Justin Yang, MBA, Catalyst Office Director
Published Date: 11/12/2020 3:42:00 PM
Category: Medical Countermeasures; National Health Security;

Partner with us to build a portfolio of next-generation of medical countermeasures using a cutting-edge business solution

After an extensive assessment of the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE) in 2010, HHS found systemic gaps in the federal government’s ability to develop necessary medical countermeasures during an emergency. The review panel recommended the creation of an independent strategic investment entity to fund efforts aimed at mitigating such risks. The 21st Century Cures Act provided BARDA with the necessary authority to  Read more…

The Evolution of Influenza Preparedness during the COVID-19 Pandemic

Author: Kristin L DeBord, PhD,Director, Strategy Division, HHS Office of the Assistant Secretary for Preparedness and Response
Published Date: 6/29/2020 1:12:00 PM
Category: Hospital Preparedness; Medical Countermeasures; National Health Security; Public Health Preparedness;

New Federal Strategy Brings Continued Focus to Modernizing the Domestic Development and Manufacturing of Life-Saving Influenza Vaccines

On September 19, 2019, President Trump issued an executive order calling on public and private partners to modernize influenza vaccines to strengthen national security and public health. Today, I am proud to announce that the National Influenza Vaccine Modernization Strategy 2020-2030 has been released.  This strategy is aimed at building domestic capacity and capability through the use of new technologies to speed up the overall  Read more…

Why sepsis solutions can help COVID-19 patients

Author: Kimberly Sciarretta, Ph.D., BARDA DRIVe Solving Sepsis Program Manager, and Meghan Pennini, Ph.D., Solving Sepsis Project Officer
Published Date: 6/22/2020 3:02:00 PM
Category: Hospital Preparedness; Medical Countermeasures; National Health Security; Public Health Preparedness; Response & Recovery;


Assessing sepsis predictive technologies to aid in the pandemic response

In the current pandemic, ICUs worldwide are caring for COVID-19 patients with life-threatening multiple organ dysfunction, in other words, sepsis. This trend provides a stark reminder that sepsis is likely to arise as a secondary confounder of any health security threat, whether in the current coronavirus pandemic or a future public health emergency.

BARDA focuses on developing safe, effective medical countermeasures, such as vaccines, trea  Read more…

New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security

Author: Rick A. Bright, Ph.D., BARDA Director and Deputy Assistant Secretary for Preparedness and Response
Published Date: 2/3/2020 10:32:00 AM
Category: National Health Security; Medical Countermeasures; Public Health Preparedness;

Innovative FDA-licensed vaccine and domestic manufacturing capacity investment bolster domestic pandemic preparedness

On January 31, 2020, we achieved a major milestone in pandemic influenza preparedness:  the U.S Food and Drug Administration’s licensure of AUDENZTM, the first adjuvanted, cell-based influenza vaccine designed to protect our nation from the H5N1 avian influenza virus.  AUDENZTM, which was developed by Seqirus with support from the Biomedical Advanced Research and Development Authority (BARDA) within the Office o  Read more…

The skyrocketting need for speed: partnering to develop rapid diagnostic tests that protect patients from antibiotic resistant infections during disasters and every day

Author: Rick Bright, Ph.D., BARDA Director and Deputy Assistant Secretary for Preparedness and Response
Published Date: 1/8/2020 1:32:00 PM
Category: Medical Countermeasures; National Health Security; Public Health Preparedness; Hospital Preparedness; Innovations;

Relatively minor injuries, like a cut that I got while gardening, can quickly become more serious if they become infected with antibiotic-resistant bacteria. Today, doctors often don’t have the diagnostic tests needed to inform patient care, and the tests that do exist may take too long to provide results. Without this vital information, doctors don’t have the information they need to ensure patients are getting the right antibiotics, serve as good stewards of antibiotics to prevent resistance, or when   Read more…

Resolving to Be Ready to Protect Critical Infrastructure

Author: Laura Kwinn Wolf, Ph.D., Director, ASPR Division of Critical Infrastructure Protection
Published Date: 1/3/2020 11:38:00 AM
Category: Public Health Preparedness; National Health Security;


Three Ways for Public Health and Medical Professionals to Enhance Preparedness


As we look forward into 2020, many of us are taking a moment to pause and consider what is coming in the next year. If you are a health care or public health professional, there is a very real chance you could be called on to respond to a disaster or emergency. In 2019, the Federal Emergency Management Agency issued one hundred disaster declarations across the 48 continental United States and territories. If a disaster strikes in your community, are you ready to respond?<  Read more…

Making history: the world’s first FDA-approved Ebola vaccine

Author: Robert Kadlec, MD, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
Published Date: 12/19/2019 7:31:00 PM
Category: Medical Countermeasures; National Health Security; Public Health Preparedness; Response & Recovery;

Public-private partners collaborate to prevent the spread of a global health threat

Today, we achieved a historic milestone in global health security with the approval of ERVEBO®, the first vaccine approved by the U.S. Food and Administration (FDA) for the prevention of the Ebola virus disease (EVD). A safe and effective vaccine is a vital tool in combatting the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC), which is the second largest outbreak since the virus was discovered in 1976. Today’s approval by the FDA, which follows last month’s Europ  Read more…

The health security threat in my backyard: how my garden proved that the U.S. needs more, rapid, diagnostics for antimicrobial resistant infections

Author: Rick Bright, Ph.D., BARDA Director and Deputy Assistant Secretary for Preparedness and Response
Published Date: 12/17/2019 1:53:00 PM
Category: National Health Security; Medical Countermeasures; Hospital Preparedness;

Although a range of health security threats - from bad actors to new infectious diseases - loom and are always emerging, I fell victim to a threat in my own backyard: an antibiotic resistant infection. To complicate matters, I couldn’t get an accurate diagnosis until it was almost too late. But the delayed diagnosis didn’t just threaten my health – it also added to healthcare costs, led to the misguided use of antibiotics, and potentially threatened the health of other patients in a hospital.

Last year, I cut my thumb while gardening. At first, I didn’t think much about  Read more…

There’s No Such Thing as Just-in-time Healthcare and Public Health Preparedness

Author: CDR Thomas J (TJ) Christl, Branch Chief of the Infrastructure Analysis and Partnerships Branch in the HHS/ASPR Division of Critical Infrastructure Protection and Rachel Lehman Stakeholder Engagement Policy Analyst of the Infrastructure Analysis and Partnerships Branch in the HHS/ASPR Division of Critical Infrastructure Protection
Published Date: 11/25/2019 11:25:00 AM
Category: Cyber Security; National Health Security; Public Health Preparedness;

How to Create and Strengthen Partnerships to Enhance Critical Infrastructure Protection

What does it take to provide patient care? The image of a hospital or doctor’s office just popped into your mind, right? Well, that’s just part of the answer.

Every day, patients rely on complex just-in-time systems for the provision of healthcare. These systems include not only hospitals and other healthcare providers, but also insurance providers, laboratories, medical device suppliers, and more.

Working together, these systems can provide just-in-time supplies  Read more…

Take a Shot at Decreasing Hospital Acquired Infections and Enhancing National Health Security

Author: Domestic Policy Branch, HHS/ASPR Office of Strategy, Policy, Planning and Requirements
Published Date: 11/6/2019 10:18:00 AM
Category: National Health Security; Hospital Preparedness; Public Health Preparedness;

A Case for Encouraging Seasonal Influenza Vaccination among Healthcare Workers


Last year marked the 100th anniversary of the 1918 influenza pandemic, which killed approximately 675,000 people in the United States according to the Centers for Disease Control and Prevention (CDC).  Although that number is daunting, it doesn't take a pandemic for influenza to seriously threaten patient health.  The disease burden for seasonal flu is still stunning 100  Read more…

The power of partnership: BARDA ushers in 50th FDA-approved product for health security

Author: Rick Bright, Ph.D., BARDA Director and Deputy Assistant Secretary for Preparedness and Response
Published Date: 10/11/2019 2:49:00 PM
Category: Medical Countermeasures; Observances; National Health Security;

At BARDA, we are proud to have established unique partnerships with industry that create solutions for the American people. By working together, we have earned – as of last week – our 50th and 51st U.S. Food and Drug Administration (FDA) approvals, licensures and clearances in the past 12 years for products that address some of our nation’s most challenging health security threats. BARDA and our private sector partners achieved eight of these in the past year alone, substantially increasing the nation’s health security preparedness.

 

Read more…

Crossing the Finish Line: Project BioShield is Transforming the Nation’s Health Security with Cutting-Edge Innovation, Sound Investments, and Strong Partnerships

Author: Rick A. Bright, Ph.D., BARDA Director
Published Date: 8/7/2019 10:53:00 AM
Category: Medical Countermeasures; Innovations; National Health Security;

Project BioShield is revolutionizing the way we protect Americans from 21st century health security threats. Think back almost 18 years ago to the anthrax attacks of 2001. That crisis highlighted just how few medical countermeasures our nation had to respond to a bioterrorism incident. The anthrax attacks taught us important lessons that still guide our thinking:  innovation is critical, partnerships matter, and the threats that we face are very real and very serious.


21st Century Health Security Threats: From Anthrax to the Unknown

Alth  Read more…

Project BioShield Evolution: Fifteen Years of Bridging the ‘Valley of Death’ in the Medical Countermeasures Pipeline

Author: By Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response
Published Date: 7/17/2019 12:15:00 PM
Category: Innovations; Medical Countermeasures; National Health Security;

Saving lives in a public health emergency requires cutting-edge medical countermeasures: medications, vaccines, diagnostics, and more. In some types of emergencies, like an act of bioterrorism, some of those medical products have no commercial market. People don’t use an anthrax antitoxin every day – thank goodness. Yet that lack of commercial market also means pharmaceutical or biotech companies had only one possible buyer for their products: the federal government for stockpiling.

In 2004, Congress passed the Project BioShield Act to create a market for products   Read more…

Pandemic and All-Hazards Preparedness and Advancing Innovation Act 2019: What Does It Mean for Me and My Organization?

Author: By Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response
Published Date: 6/25/2019 10:54:00 AM
Category: Public Health Preparedness; Response & Recovery; National Health Security;

At ASPR, we’re excited about the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA), which the president signed last night. The new law strengthens public health and healthcare readiness, bolsters response and recovery programs, and increases transparency. What do the changes mean for our non-federal partners? We see some key provisions that can significantly improve preparedness and response for our partners.

Improving preparedness

PAHPAIA authorized a funding increase for the Hospital Pr  Read more…

Project BioShield: Enhancing Preparedness, Ensuring Treatment Options

Author: Brian Tse, Oxana Selivanova, Claiborne Hughes, and Mark Albrecht
Published Date: 5/13/2019 9:42:00 AM
Category: Public Health Preparedness; Medical Countermeasures; National Health Security;


Stockpiling Novel Antibiotics Safeguards Nation, Sustains Commitment to Industry

Bacteria evolve and change, becoming more dangerous and deadly, and often developing resistance to existing medical countermeasures. Consider some of the resistance problems we face today. In recent years, we’ve seen increasing incidences of multi-drug resistant salmonella, gonorrhea, and typhoid, just to name a few examples. Now, think about what would happen if evolution or terrorists created antibiotic-resistant strains of biothreat agents, such as anthrax, plague, tularemia, mel  Read more…

Help guide the future of disaster health readiness, response, and recovery

Author: Christopher L. Perdue, MD, MPH, Commander (CDR), US Public Health Service, Senior Policy Coordinator, HHS/ASPR Office of Strategy, Policy, Planning, and Requirements
Published Date: 5/7/2019 4:05:00 PM
Category: National Health Security; Public Health Preparedness;

HHS seeks outside experts for national advisory committee

Disaster readiness, response, and recovery are complex and the threats involved continue to evolve. The nation faces a myriad of potentially challenging health effects following a disaster. The HHS Secretary depends on the advice, expertise, and counsel of outside experts from the National Biodefense Science Board for recommendations to help make complex decisions and guide the future of disaster health preparedness, response, and recovery. Participating on the board provides a unique way to get involved in pu  Read more…

Protecting the Nation from Emerging and Pandemic Infectious Diseases and CBRN Threats

Author: Darrin Donato, Senior Policy Analyst for the Office of Strategy, Policy, Planning, and Requirements within HHS’ Office of the Assistant Secretary for Preparedness and Response and Michael Fucci, Jr. Management Analyst with Aveshka Inc. in support of the Office of Strategy, Policy, Planning, and Requirements, HHS Office of the Assistant Secretary for Preparedness and Response
Published Date: 2/13/2019 9:26:00 AM
Category: Medical Countermeasures; National Health Security;

National Health Security Strategy:  Blog 3

As we scan the threat landscape as a new year begins, we find that we face a range of evolving threats to national health security. Among these risk are emerging infectious diseases that could lead to pandemic and the potential for chemical, biological, radiological, and nuclear (CBRN) emergencies.

An increasing number of immunocompromised and/or unvaccinated people (especially children), global mobility, population density acceleration, urbanization, and a growi  Read more…

Whole-of-Government Approach: What It Means and How It Translates to Improving National Health Security

Author: Daniel Dodgen, Ph.D., Senior Advisor, HHS Office of the Assistant Secretary for Preparedness and Response
Published Date: 2/6/2019 9:46:00 AM
Category: National Health Security; Public Health Preparedness;

National Health Security Strategy Blog Series: Part 2

The Department of Health and Human Services (HHS) has published its quadrennial strategy to safeguard the nation’s health in times of crisis. The 2019-2022 National Health Security Strategy (NHSS) provides a vision to strengthen the nation’s ability to prevent, detect, assess, prepare for, mitigate, respond to, and recover from disasters and emergencies.

The new strategy focuses on three overarching objectives: 1) prepare, mobilize, and co  Read more…

1 2 3 4